Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy.
Saved in:
| Title: | Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. |
|---|---|
| Authors: | Alsoudi AF; Department of Ophthalmology, Baylor College of Medicine, Houston, Texas., Loya A; Department of Ophthalmology, Baylor College of Medicine, Houston, Texas., Wai K; Horngren Family Vitreoretinal Center, Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California., Koo E; Horngren Family Vitreoretinal Center, Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California., Weng CY; Department of Ophthalmology, Baylor College of Medicine, Houston, Texas., Mruthyunjaya P; Horngren Family Vitreoretinal Center, Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California., Rahimy E; Horngren Family Vitreoretinal Center, Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California.; Department of Ophthalmology, Palo Alto Medical Foundation, Palo Alto, California. |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2025 Sep 01; Vol. 143 (9), pp. 777-784. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6173 |
|---|---|
| DOI: | 10.1001/jamaophthalmol.2025.2497 |
